Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial
一项开放标签、双中心、多臂随机I期试验，评估改良型COVID-19 mRNA疫苗SW-BIC-213作为异源加强针在健康成人中的安全性和免疫原性。
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2023.104586
Gui, Yu-Zhou; Li, Xue-Ning; Li, Jing-Xin; Shen, Ming-Yun; Zhang, Mei-Wei; Cao, Ye; Xu, Hong-Rong; Li, Hui; Cheng, Jie; Pan, Liang; Yi, Ying-Lei; Liang, Li-Yu; Yu, Cheng-Yin; Liu, Gang-Yi; Yu, Chen; Hu, Bi-Jie; Zhu, Feng-Cai; Liang, Fei; Shen, Haifa; Jia, Jing-Ying; Li, Hang-Wen; Zhou, Jian; Fan, Jia
